Semus Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-8,293
Closed -$339K – 122
2024
Q2
$339K Sell
8,293
-2,638
-24% -$105K 0.26% 72
2024
Q1
$453K Sell
10,931
-814
-7% -$34.1K 0.38% 59
2023
Q4
$475K Sell
11,745
-592
-5% -$22.6K 0.39% 58
2023
Q3
$483K Sell
12,337
-833
-6% -$33.2K 0.45% 52
2023
Q2
$535K Hold
13,170
– – 0.49% 49
2023
Q1
$551K Sell
13,170
-53
-0.4% -$2.23K 0.59% 41
2022
Q4
$576K Buy
+13,223
New +$562K 0.7% 39

Other funds holding BME

Semus Wealth Partners's BME Position: Q3 2024 in Review

Semus Wealth Partners sold out of BlackRock Health Sciences Trust (BME) in Q3 2024, closing a stake of 8,293 shares — an estimated $339K sold.

Semus Wealth Partners first reported a position in BME in Q4 2022 and held it in 7 quarters. The position peaked at $576K in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q3 2024.

  • Semus Wealth Partners reported no remaining BlackRock Health Sciences Trust position as of Q3 2024 after selling out during the quarter.
  • Semus Wealth Partners sold 8,293 BlackRock Health Sciences Trust shares in Q3 2024, an estimated $339K.
  • Semus Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q4 2022 and held it in 7 quarters.
  • Semus Wealth Partners's BlackRock Health Sciences Trust position peaked at $576K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2024.

Based on Semus Wealth Partners's 13F filing for Q3 2024, filed 7 Nov 2024.